"They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
Coronavirus
Immunization
Pandemic
Vaccine hesitancy
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
28 11 2022
28 11 2022
Historique:
received:
01
06
2022
revised:
19
10
2022
accepted:
24
10
2022
pubmed:
6
11
2022
medline:
23
11
2022
entrez:
5
11
2022
Statut:
ppublish
Résumé
Vaccination is an essential public health intervention to control the COVID-19 pandemic. A minority of Canadians, however, remain hesitant about COVID-19 vaccines, while others outright refuse them. We conducted focus groups to gauge perceptions and attitudes towards COVID-19 vaccines in people who live in a region with historically low rates of childhood vaccination. Participants discussed their perception of COVID-19 vaccines and their intention to get vaccinated, and the low rate of COVID-19 vaccine uptake in Manitoba's Southern Health Region compared to other regions in Canada. We identified three drivers of vaccine hesitancy: (1) risk perceptions about COVID-19 and the vaccines developed to protect against it, (2) religious and conservative views; and (3) distrust in government and science. Participant proposed recommendations for improving communication and uptake of the COVID-19 vaccines included: public health messages emphasising the benefits of vaccination; addressing the community's specific concerns and dispelling misinformation; highlighting vaccine safety; and emphasising vaccination as a desirable behaviour from a religious perspective. Understanding the specific anxieties elicited by COVID-19 vaccines in areas with low childhood immunization rates can inform risk communication strategies tailored to increase vaccination in these specific regions. This study adds important information on potential reasons for vaccine hesitancy in areas with historically low rates of childhood vaccination, and provides important lessons learned for future emergencies in terms of vaccine hesitancy drivers and effective risk communication to increase vaccine uptake.
Identifiants
pubmed: 36334965
pii: S0264-410X(22)01338-X
doi: 10.1016/j.vaccine.2022.10.058
pmc: PMC9618440
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7280-7287Subventions
Organisme : CIHR
ID : OV6–170370
Pays : Canada
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Clin Infect Dis. 2019 Aug 1;69(4):726-731
pubmed: 30753348
Vaccines (Basel). 2021 Dec 24;10(1):
pubmed: 35062683
Med (N Y). 2021 May 14;2(5):498-501
pubmed: 33851144
BMC Public Health. 2021 May 29;21(1):1017
pubmed: 34051770
Pers Individ Dif. 2021 Jan 1;168:110289
pubmed: 32834288
Eur J Epidemiol. 2021 Jul;36(7):709-714
pubmed: 34037927
Toxicol Lett. 2004 Apr 1;149(1-3):391-7
pubmed: 15093286
Z Gesundh Wiss. 2022 Jan 07;:1-25
pubmed: 35018277
Vaccine. 2021 Oct 29;39(45):6614-6621
pubmed: 34629205
JAMA. 2021 Sep 28;326(12):1145-1146
pubmed: 34424275
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):
pubmed: 33443149
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Vaccine. 2022 Apr 6;40(16):2442-2456
pubmed: 35305823
Vaccines (Basel). 2021 Nov 30;9(12):
pubmed: 34960162
Health Policy. 2001 Mar;55(3):159-72
pubmed: 11164965
Pers Individ Dif. 2021 Jun;175:110734
pubmed: 33583988
Am J Infect Control. 2021 Feb;49(2):137-142
pubmed: 33227323
Vaccine. 2021 Jun 11;39(26):3473-3479
pubmed: 34023134
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
BMC Public Health. 2012 Jun 06;12:408
pubmed: 22672710
J Community Psychol. 2022 Apr;50(3):1269-1281
pubmed: 34551127
J Relig Health. 2017 Oct;56(5):1683-1691
pubmed: 28631171
Int J Clin Pract. 2021 Feb;75(2):e13778
pubmed: 33480171
Lancet. 2022 Jan 29;399(10323):412-413
pubmed: 35065007
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Public Health. 2021 May;194:245-251
pubmed: 33965796
J Public Health (Oxf). 2021 Sep 22;43(3):e529-e530
pubmed: 34080617
Lancet Reg Health Am. 2021 Oct;2:100055
pubmed: 34467260
Vaccine. 2021 Dec 20;39(52):7669-7676
pubmed: 34688500